Attempts towards oral diabetes therapy by means of inhibition of lipolysis with 5-methylpyrazole-3-carbonic acid.
D000284:Administration, Oral; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D002245:Carbon Dioxide / Q000494:pharmacology; D002264:Carboxylic Acids / Q000627:therapeutic use; D003864:Depression, Chemical; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D004032:Diet; D004035:Diet Therapy; D004040:Dietary Carbohydrates / Q000378:metabolism; D005069:Evaluation Studies as Topic; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006029:Glycosuria / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008660:Metabolism / Q000187:drug effects; D009132:Muscles / Q000378:metabolism; D009747:Nutritional Physiological Phenomena; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D002264:Carboxylic Acids; D004040:Dietary Carbohydrates; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D008055:Lipids; D011720:Pyrazoles; D014280:Triglycerides; D002245:Carbon Dioxide; D006003:Glycogen; D005947:Glucose